ATNM vs KEY · rev $35.0M vs P/E 13, rev $3.92B
Actinium Pharmaceuticals Inc (ATNM) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported KEY revenue for 2026-06-30 was $3.92B. Net income was $1.03B. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
ATNM currently screens at market cap $33.9M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the ATNM and KEY stock pages for the full models.
Not investment advice.